Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A

Journal of the Formosan Medical Association

Volumn 96, Issue 7, 1997, Pages 542-544

  Huang, Shih Ming ^a   Tao, Bor Lin ^b   Tzeng, Ching Cherng ^b   Liu, Hsin Tzu ^a   Wang, Wen Pin ^a,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

amniocentesis; multiple endocrine neoplasia type 2A; RET proto oncogene

Indexed keywords

AMNIOCENTESIS; ARTICLE; CASE REPORT; DNA DETERMINATION; FEMALE; FETUS; FOLLOW UP; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS; PROTO ONCOGENE; SIPPLE SYNDROME;

ADULT; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0030849985     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cance WG, Wells SA: Multiple endocrine neoplasia type IIa. Curr Probl Surg 1985;22:1-56.
2. Howe JR, Norton JA, Wells SA, et al: Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 1993;114:1070-7.
3. 131IMIBG as an aid to the treatment of pheochromocytomas in patients with the multiple endocrine neoplasia type 2 syndromes. Henry Ford Hosp Med J 1984;32:254-61.
4. Gagel RF, Tashjian AH, Cumming T, et al: The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. New Engl J Med 1988;318:478-84.
5. Gagel RF, Jackson CE, Block MA, et al: Age-related probability of development of hereditary medullary thyroid carcinoma. J Pediatr 1982;101:941-6.
6. Chi DD, Toshima K, Helen DK, et al: Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET proto-oncogene. Surgery 1994;16:124-33.
7. Wells SA, Chi DD, Toshima K, et al: Predictive DNA testing and prophylactic thyroidectomy in patientsatrisk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-50.
8. Mulligan LM, Ponder BAJ: Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 1995; 80:1899-995.
9. Mathew CGP, Easton DF, Nakamura Y, et al: Presymtomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. Lancet 1991;337:7-11.
10. Wu MC, Chiu NT, Huang SM, et al: I-131 MIBG uptake in medullary thyroid cancer and adrenal pheochromocytoma of MEN type II. Ann Nucl Sci 1993;6:161-5.
11. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
12. Sanger F: Determination of nucleotide sequences in DNA. Science 1981;214:1205-10.